Andrew Fensome

Years Active: 2018-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Brian S Gerstenberger, Catherine Ambler, Eric P Arnold, Mary-Ellen Banker, Matthew F Brown, James D Clark, Alpay Dermenci, Martin E Dowty, Andrew Fensome, Susan Fish, Matthew M Hayward, Martin Hegen, Brett D Hollingshead, John D Knafels, David W Lin, Tsung H Lin, Dafydd R Owen, Eddine Saiah, Raman Sharma, Felix F Vajdos, Li Xing, Xiaojing Yang, Xin Yang, Stephen W Wright
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases. Journal of medicinal chemistry 63 (22) (2020)
Andrew Fensome, Catherine M Ambler, Eric Arnold, Mary Ellen Banker, Matthew F Brown, Jill Chrencik, James D Clark, Martin E Dowty, Ivan V Efremov, Andrew Flick, Brian S Gerstenberger, Ariamala Gopalsamy, Matthew M Hayward, Martin Hegen, Brett D Hollingshead, Jason Jussif, John D Knafels, David C Limburg, David Lin, Tsung H Lin, Betsy S Pierce, Eddine Saiah, Raman Sharma, Peter T Symanowicz, Jean-Baptiste Telliez, John I Trujillo, Felix F Vajdos, Fabien Vincent, Zhao-Kui Wan, Li Xing, Xiaojing Yang, Xin Yang, Liying Zhang
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841). Journal of medicinal chemistry 61 (19) (2018)

Andrew Fensome.css-eqlu8i{font-size:small;padding-left:4px;}